Fortis Healthcare Ltd.(IN:FORTIS)
₹760.00-9.50 (-1.23%)
IN:FORTIS
Fortis Healthcare Ltd. financials statements
₹760.00
At close:-9.50 (-1.23%)
Want to see IN:FORTIS full AI Analyst Report?
Fortis Healthcare Ltd. (FORTIS) Ratios
8 Followers
Fortis Healthcare Ltd. Ratios
IN:FORTIS's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:FORTIS's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.86 | 0.92 | 0.45 | 0.99 | 0.89 |
| Quick Ratio | 0.80 | 0.84 | 0.41 | 0.90 | 0.80 |
| Cash Ratio | 0.19 | 0.32 | 0.07 | 0.10 | 0.11 |
| Solvency Ratio | 0.26 | 0.24 | 0.18 | 0.19 | 0.16 |
| Operating Cash Flow Ratio | 0.65 | 0.89 | 0.35 | 0.58 | 0.68 |
| Short-Term Operating Cash Flow Coverage | 2.94 | 12.99 | 9.37 | 6.28 | 4.64 |
| Net Current Asset Value | ₹ -39.78B | ₹ -30.51B | ₹ -33.12B | ₹ -29.27B | ₹ -37.43B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.18 | 0.09 | 0.07 | 0.11 |
| Debt-to-Equity Ratio | 0.35 | 0.28 | 0.15 | 0.13 | 0.20 |
| Debt-to-Capital Ratio | 0.26 | 0.22 | 0.13 | 0.11 | 0.17 |
| Long-Term Debt-to-Capital Ratio | 0.20 | 0.19 | 0.09 | 0.07 | 0.11 |
| Financial Leverage Ratio | 1.61 | 1.54 | 1.73 | 1.72 | 1.92 |
| Debt Service Coverage Ratio | 2.33 | 4.63 | 3.92 | 3.27 | 2.45 |
| Interest Coverage Ratio | 5.20 | 24.30 | 27.73 | 15.49 | 21.56 |
| Debt to Market Cap | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 |
| Interest Debt Per Share | 50.17 | 35.08 | 17.03 | 13.97 | 18.46 |
| Net Debt to EBITDA | 1.44 | 1.31 | 0.77 | 0.76 | 1.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 36.63% | 58.90% | 57.61% | 36.65% | 56.41% |
| EBIT Margin | 18.41% | 15.34% | 13.33% | 12.46% | 13.30% |
| EBITDA Margin | 23.33% | 19.26% | 17.21% | 16.46% | 17.41% |
| Operating Profit Margin | 17.92% | 53.56% | 52.65% | 31.75% | 52.38% |
| Pretax Profit Margin | 14.96% | 12.93% | 12.44% | 13.02% | 17.28% |
| Net Profit Margin | 11.41% | 9.94% | 8.68% | 9.35% | 9.71% |
| Continuous Operations Profit Margin | 11.66% | 10.40% | 9.35% | 10.05% | 13.82% |
| Net Income Per EBT | 76.27% | 76.88% | 69.80% | 71.80% | 56.20% |
| EBT Per EBIT | 83.51% | 24.15% | 23.62% | 41.00% | 32.98% |
| Return on Assets (ROA) | 6.52% | 5.65% | 4.51% | 4.73% | 4.67% |
| Return on Equity (ROE) | 10.53% | 8.68% | 7.82% | 8.13% | 8.99% |
| Return on Capital Employed (ROCE) | 11.81% | 34.51% | 35.89% | 18.17% | 28.21% |
| Return on Invested Capital (ROIC) | 8.86% | 27.37% | 26.55% | 13.81% | 22.10% |
| Return on Tangible Assets | 9.81% | 8.50% | 6.90% | 7.49% | 7.48% |
| Earnings Yield | 1.74% | 1.49% | 1.85% | 3.00% | 2.53% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.72 | 9.87 | 10.76 | 10.78 | 11.07 |
| Payables Turnover | 6.13 | 3.96 | 4.02 | 5.59 | 3.49 |
| Inventory Turnover | 42.76 | 27.76 | 27.22 | 32.48 | 20.28 |
| Fixed Asset Turnover | 1.25 | 1.25 | 1.18 | 1.24 | 1.11 |
| Asset Turnover | 0.57 | 0.57 | 0.52 | 0.51 | 0.48 |
| Working Capital Turnover Ratio | -42.30 | -8.26 | -7.80 | -80.90 | -34.40 |
| Cash Conversion Cycle | -9.14 | -41.97 | -43.53 | -20.26 | -53.65 |
| Days of Sales Outstanding | 41.83 | 36.98 | 33.91 | 33.86 | 32.96 |
| Days of Inventory Outstanding | 8.54 | 13.15 | 13.41 | 11.24 | 18.00 |
| Days of Payables Outstanding | 59.51 | 92.11 | 90.85 | 65.35 | 104.61 |
| Operating Cycle | 50.37 | 50.13 | 47.32 | 45.09 | 50.96 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 18.34 | 18.87 | 14.57 | 10.89 | 11.46 |
| Free Cash Flow Per Share | 5.81 | 7.65 | 2.09 | 4.97 | 8.61 |
| Dividend Paid and CapEx Coverage Ratio | 1.35 | 1.49 | 1.07 | 1.78 | 4.02 |
| Capital Expenditure Coverage Ratio | 1.46 | 1.68 | 1.17 | 1.84 | 4.02 |
| Operating Cash Flow Coverage Ratio | 0.40 | 0.58 | 0.95 | 0.89 | 0.69 |
| Operating Cash Flow to Sales Ratio | 0.15 | 0.18 | 0.16 | 0.13 | 0.15 |
| Free Cash Flow Yield | 0.73% | 1.11% | 0.49% | 1.91% | 2.96% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 57.61 | 67.12 | 54.07 | 33.33 | 39.49 |
| Price-to-Sales (P/S) Ratio | 6.58 | 6.67 | 4.70 | 3.12 | 3.83 |
| Price-to-Book (P/B) Ratio | 6.06 | 5.83 | 4.23 | 2.71 | 3.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 136.79 | 90.06 | 205.44 | 52.32 | 33.73 |
| Price-to-Operating Cash Flow Ratio | 43.36 | 36.49 | 29.44 | 23.86 | 25.33 |
| Price-to-Earnings Growth (PEG) Ratio | 1.67 | 2.28 | 32.44 | 5.44 | -0.07 |
| Enterprise Value Multiple | 29.62 | 35.96 | 28.06 | 19.68 | 23.14 |
| Enterprise Value | 630.81B | 539.32B | 333.04B | 204.06B | 230.36B |
| EV to EBITDA | 29.62 | 35.96 | 28.06 | 19.68 | 23.14 |
| EV to Sales | 6.91 | 6.93 | 4.83 | 3.24 | 4.03 |
| EV to Free Cash Flow | 143.78 | 93.47 | 211.28 | 54.42 | 35.44 |
| EV to Operating Cash Flow | 45.57 | 37.88 | 30.27 | 24.82 | 26.62 |
| Tangible Book Value Per Share | 63.90 | 60.84 | 52.30 | 46.67 | 33.68 |
| Shareholders’ Equity Per Share | 131.08 | 118.16 | 101.50 | 95.93 | 81.84 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.20 | 0.25 | 0.23 | 0.20 |
| Revenue Per Share | 120.91 | 103.18 | 91.36 | 83.42 | 75.73 |
| Net Income Per Share | 13.80 | 10.26 | 7.93 | 7.80 | 7.35 |
| Tax Burden | 0.76 | 0.77 | 0.70 | 0.72 | 0.56 |
| Interest Burden | 0.81 | 0.84 | 0.93 | 1.05 | 1.30 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.05 | 0.01 | 0.01 | 0.01 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.33 | 1.84 | 1.84 | 1.01 | 0.88 |
Currency in INR
